Medline (MDLN) Receivables - Net (2024 - 2026)

Medline (MDLN) has 3 years of Receivables - Net data on file, last reported at $3.7 billion in Q1 2026.

• Quarterly Receivables - Net changed N/A year-over-year to $3.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (changed N/A YoY) and the FY2025 annual result came in at $3.5 billion, up 9.75% from the prior year.
• Receivables - Net rose to $3.7 billion in Q1 2026 per MDLN's latest filing, from $3.5 billion in the prior quarter.
• Across five years, Receivables - Net topped out at $3.7 billion in Q1 2026 and bottomed at $3.2 billion in Q4 2024.
• The 3-year median for Receivables - Net is $3.5 billion (2025), against an average of $3.5 billion.
• Peak annual rise in Receivables - Net reached 9.75% in 2025, while the deepest fall reached 9.75% in 2025.
• Tracing MDLN's Receivables - Net over 3 years: stood at $3.2 billion in 2024, then climbed by 9.75% to $3.5 billion in 2025, then grew by 3.99% to $3.7 billion in 2026.
• Per Business Quant, the three latest MDLN Receivables - Net figures stand at $3.7 billion (Q1 2026), $3.5 billion (Q4 2025), and $3.2 billion (Q4 2024).

Peer Comparison